Cancer of unknown primary : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 34(2023), 3 vom: 05. März, Seite 228-246 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krämer, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Classification |
|---|
| Anmerkungen: |
Date Completed 24.02.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.annonc.2022.11.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350754764 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350754764 | ||
| 003 | DE-627 | ||
| 005 | 20231226045717.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2022.11.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350754764 | ||
| 035 | |a (NLM)36563965 | ||
| 035 | |a (PII)S0923-7534(22)04769-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krämer, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cancer of unknown primary |b ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.02.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Classification | |
| 650 | 4 | |a ESMO Clinical Practice Guideline | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a risk assessment | |
| 650 | 4 | |a treatment | |
| 650 | 4 | |a unknown primary neoplasm | |
| 700 | 1 | |a Bochtler, T |e verfasserin |4 aut | |
| 700 | 1 | |a Pauli, C |e verfasserin |4 aut | |
| 700 | 1 | |a Baciarello, G |e verfasserin |4 aut | |
| 700 | 1 | |a Delorme, S |e verfasserin |4 aut | |
| 700 | 1 | |a Hemminki, K |e verfasserin |4 aut | |
| 700 | 1 | |a Mileshkin, L |e verfasserin |4 aut | |
| 700 | 1 | |a Moch, H |e verfasserin |4 aut | |
| 700 | 1 | |a Oien, K |e verfasserin |4 aut | |
| 700 | 1 | |a Olivier, T |e verfasserin |4 aut | |
| 700 | 1 | |a Patrikidou, A |e verfasserin |4 aut | |
| 700 | 1 | |a Wasan, H |e verfasserin |4 aut | |
| 700 | 1 | |a Zarkavelis, G |e verfasserin |4 aut | |
| 700 | 1 | |a Pentheroudakis, G |e verfasserin |4 aut | |
| 700 | 1 | |a Fizazi, K |e verfasserin |4 aut | |
| 700 | 0 | |a ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 34(2023), 3 vom: 05. März, Seite 228-246 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2023 |g number:3 |g day:05 |g month:03 |g pages:228-246 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2022.11.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2023 |e 3 |b 05 |c 03 |h 228-246 | ||